Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ST13P20, short for "suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 20," is a non-protein-coding pseudogene in the human genome, catalogued under NCBI Gene ID 729828 and located on chromosome 1[1][4][6][8][11]. Pseudogenes are gene sequences resembling known genes but are generally non-functional due to mutations or lack of regulatory elements, and ST13P20 does not encode a functional Hsp70-interacting protein. There are no reports of biological or disease associations, and it is not considered a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) pseudogene 20 (ST13P20).